Boston Scientific’s Watchman left atrial appendage (LAA) closure device to prevent stroke resulted in significantly less bleeding after an ablation procedure than taking blood thinners ...

The WATCHMAN(TM) Left Atrial Appendage Closure Device from Boston Scientific is an implant used to block the left atrial appendage of the heart, a common area for blood clot formations in patients ...

Boston Scientific (BSX – Research Report ... which demonstrated the effectiveness and safety of the Watchman FLX device. The trial showed that the device is not only comparable in efficacy ...

Boston Scientific’s BSX robust expansion of operations across different geographies outside the United States is poised to help it grow in the upcoming quarters. The company’s Electrophysiology (EP) ...

Boston Scientific is diving into the field of intravascular lithotripsy, with a $664 million deal to pick up Bolt Medical and ...

On Oct. 10, Boston Scientific sent an urgent medical device advisory to all affected customers with recommendations. Boston's device is used in ablation procedures to treat recurrent symptomatic ...

Boston Scientific is Thursday's IBD Stock Of The Day as the medtech trades just below all-time highs it hit late last month.

Boston Scientific has updated its instructions for ... reserved for situations when there’s a reasonable chance that using a device without following updated instructions would lead to serious ...

Boston Scientific Corporation (NYSE ... from the OPTION global clinical trial of the WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device. Key findings from the study comparing the device ...

The deal for Bolt, developer of an intravascular lithotripsy system to treat coronary and peripheral artery disease, ...